CRDF
Cardiff Oncology Inc
NASDAQ: CRDF · HEALTHCARE · BIOTECHNOLOGY
$1.73
+6.79% today
Updated 2026-04-30
Market cap
$117.60M
P/E ratio
—
P/S ratio
198.31x
EPS (TTM)
$-0.69
Dividend yield
—
52W range
$1 – $5
Volume
0.7M
Cardiff Oncology Inc (CRDF) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-3,221.00%
ROE
-71.50%
ROA
-38.50%
Debt/equity
0.02x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2004 | — | $-5.37M | — | — | — |
| 2005 | — | $-7.84M | — | — | — |
| 2009 | $650000.00 | $-2.48M | 100.00% | -367.69% | -381.54% |
| 2010 | $265665.00 | $-5.45M | 100.00% | -2,024.84% | -2,051.13% |
| 2011 | $257696.00 | $-2.24M | 100.00% | -1,155.16% | -868.94% |
| 2012 | $450000.00 | $-11.57M | -326.73% | -1,077.56% | -2,570.22% |
| 2013 | $259246.00 | $-11.81M | -1,242.91% | -4,123.71% | -4,555.88% |
| 2014 | $280000.00 | $-14.32M | 94.64% | -5,337.50% | -5,116.07% |
| 2015 | $313000.00 | $-27.47M | -100.96% | -8,074.76% | -8,776.68% |
| 2016 | $381000.00 | $-39.20M | -354.07% | -10,536.75% | -10,289.76% |
| 2017 | $505000.00 | $-24.91M | -258.61% | -5,068.51% | -4,932.08% |
| 2018 | $378000.00 | $-16.46M | -57.94% | -4,511.38% | -4,354.76% |
| 2019 | $244632.00 | $-16.41M | 100.00% | -6,817.79% | -6,709.74% |
| 2020 | $366000.00 | $-19.31M | 100.00% | -5,214.75% | -5,275.14% |
| 2021 | $359000.00 | $-28.29M | 100.00% | -8,037.60% | -7,880.50% |
| 2022 | $386000.00 | $-38.70M | 100.00% | -10,337.31% | -10,026.94% |
| 2023 | $488000.00 | $-41.44M | 100.00% | -9,305.74% | -8,492.01% |
| 2024 | $683000.00 | $-45.43M | 100.00% | -7,123.13% | -6,651.68% |
| 2025 | $593000.00 | $-45.88M | -52.45% | -8,256.32% | -7,736.26% |